Literature DB >> 18667375

Wilms' tumour: a complex enigma to decipher.

María José Robles-Frías1, Michele Biscuola, María Angeles Castilla, María Angeles López-García, Felicia Sánchez-Gallego, José Palacios.   

Abstract

Wilms' tumour (WT) is the most common solid tumour of childhood. The molecular signalling pathways determining the origin and behaviour of WT are very complex and several genes in several loci may participate. This review tries to briefly compile recent works on the histology and on the molecular alterations that promote the genesis, development and behaviour of WT. Some molecular alterations seem to be associated with specific histological types and particular clinical outcomes, suggesting that they might be utilised to determine the prognosis and to identify poor prognostic subgroups that can be targeted for more individualised treatments.

Entities:  

Mesh:

Year:  2008        PMID: 18667375     DOI: 10.1007/s12094-008-0233-6

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  56 in total

1.  Cancer. Converging on beta-catenin in Wilms tumor.

Authors:  Roel Nusse
Journal:  Science       Date:  2007-05-18       Impact factor: 47.728

Review 2.  Recent advances in Wilms tumor genetics.

Authors:  Jeffrey S Dome; Max J Coppes
Journal:  Curr Opin Pediatr       Date:  2002-02       Impact factor: 2.856

3.  Methylation sequencing analysis refines the region of H19 epimutation in Wilms tumor.

Authors:  M A Frevel; S J Sowerby; G B Petersen; A E Reeve
Journal:  J Biol Chem       Date:  1999-10-08       Impact factor: 5.157

4.  Loss of 11q and 16q in Wilms tumors is associated with anaplasia, tumor recurrence, and poor prognosis.

Authors:  Stefanie Wittmann; Birgit Zirn; Muhannad Alkassar; Peter Ambros; Norbert Graf; Manfred Gessler
Journal:  Genes Chromosomes Cancer       Date:  2007-02       Impact factor: 5.006

5.  Loss of methylation at chromosome 11p15.5 is common in human adult tumors.

Authors:  Rosaria A M Scelfo; Christine Schwienbacher; Angelo Veronese; Laura Gramantieri; Luigi Bolondi; Patrizia Querzoli; Italo Nenci; George A Calin; Adriano Angioni; Giuseppe Barbanti-Brodano; Massimo Negrini
Journal:  Oncogene       Date:  2002-04-11       Impact factor: 9.867

6.  [Nephroblastoma or Wilms tumor. Adult presentation. Report of two cases].

Authors:  Roberto Llarena Ibarguren; Ainara Villafruela Mateos; Igor Azurmendi Arin; Jorge García Fernández; Iban Olano Grasa; Jesús Padilla Nieva; Carlos Pertusa Peña
Journal:  Arch Esp Urol       Date:  2007-06       Impact factor: 0.436

7.  Familial Wilms' tumor: a descriptive study.

Authors:  N E Breslow; J Olson; J Moksness; J B Beckwith; P Grundy
Journal:  Med Pediatr Oncol       Date:  1996-11

8.  Relaxation of imprinted genes in human cancer.

Authors:  S Rainier; L A Johnson; C J Dobry; A J Ping; P E Grundy; A P Feinberg
Journal:  Nature       Date:  1993-04-22       Impact factor: 49.962

9.  Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signaling.

Authors:  Michael B Major; Nathan D Camp; Jason D Berndt; Xianhua Yi; Seth J Goldenberg; Charlotte Hubbert; Travis L Biechele; Anne-Claude Gingras; Ning Zheng; Michael J Maccoss; Stephane Angers; Randall T Moon
Journal:  Science       Date:  2007-05-18       Impact factor: 47.728

10.  Analysis by array CGH of genomic changes associated with the progression or relapse of Wilms' tumour.

Authors:  R Natrajan; S E Little; N Sodha; J S Reis-Filho; A Mackay; K Fenwick; A Ashworth; E J Perlman; J S Dome; P E Grundy; K Pritchard-Jones; C Jones
Journal:  J Pathol       Date:  2007-01       Impact factor: 7.996

View more
  1 in total

1.  Fine-needle aspiration cytopathology in the diagnosis of Wilms tumor.

Authors:  I Fernández-Pineda; R Cabello; J A García-Cantón; S Pérez-Bertolez; I Tuduri; G Ramírez; C Márquez; J C de Agustín
Journal:  Clin Transl Oncol       Date:  2011-11       Impact factor: 3.405

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.